Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

BIOMARIN PHARMACEUTICAL INC (BMRN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   8-K10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  -0.227.7120.8-57.9-36.512.917.417.0
Depreciation and amortization   25.327.326.026.827.228.027.4
Stock-based compensation   47.147.843.949.054.849.547.6
Deferred taxes   -1.34.8-3.6-13.2-2.13.3-35.8
Change in working capital   [+] -45.8-138.16.168.7-8.86.7-55.6
Other operating activities   3.3-108.1-3.32.2-1.38.7-14.0
Cash from operations   56.2-45.411.297.182.8113.5-13.4
   
Capital expenditures   -27.2-28.8-28.7-18.7-22.6-25.5-31.0
Purchases of intangible assets   -0.9-1.9-15.6-1.6-3.7-2.7-8.8
Purchases of short-term investments   147.4-147.4737.1-252.6237.2-237.2369.9
Other cash from investing   -149.0265.8-748.2153.1-331.2194.6-319.1
Cash from investing   -29.787.8-55.4-119.8-120.3-70.811.0
   
Option exercises   21.38.216.35.221.85.811.6
Other cash from financing   9.5-17.030.74.232.8-18.5-354.5
Cash from financing   -11.8-25.314.4-1.011.0-24.4-366.2
   
Free cash flow   29.1-74.2-17.678.360.288.0-44.4
        Per share (diluted)   $0.16($0.38)($0.10)$0.43$0.32$0.48($0.23)
   
Cash paid for interest   3.71.43.71.53.71.56.6

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy